Sun’s Specialty Gambit Paying Off, Tildrakizumab Nears Sales Milestone

About 9,000 US physicians have prescribed Winlevi

sales surge
Sun's Specialty Business Sees Uptick • Source: Alamy

More from Strategy

More from Business